tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BMY Stock Latest News

Bristol-Myers Squibb Advances Phase 3 Autism Irritability Program With KarXT Combo
Company AnnouncementsBristol-Myers Squibb Advances Phase 3 Autism Irritability Program With KarXT Combo
20h ago
BMY
The Week That Was, The Week Ahead: Macro & Markets, Dec. 28
PremiumMarket News
The Week That Was, The Week Ahead: Macro & Markets, Dec. 28
9d ago
O
DE
Trump Trade: Trump strikes deals with nine drugmakers to cut prices
PremiumThe Fly
Trump Trade: Trump strikes deals with nine drugmakers to cut prices
15d ago
CI
BMY
Bristol-Myers Squibb: Stable Cash Flows Offset by Slower Cobenfy Ramp Support Hold Rating
PremiumRatings
Bristol-Myers Squibb: Stable Cash Flows Offset by Slower Cobenfy Ramp Support Hold Rating
15d ago
BMY
Government deals lift overhang on pharma group, says BofA
PremiumThe Fly
Government deals lift overhang on pharma group, says BofA
15d ago
AZN
BMY
Cytokinetics price target raised to $99 from $95 at Goldman Sachs
PremiumThe FlyCytokinetics price target raised to $99 from $95 at Goldman Sachs
15d ago
BMY
CYTK
Dollar General, BMY, PRU, MET, Snowflake Trending With Analysts
Premium
Weekend Updates
Dollar General, BMY, PRU, MET, Snowflake Trending With Analysts
17d ago
DG
BMY
Bristol Myers agrees with U.S. to make Eliquis available on Medicaid for free
Premium
The Fly
Bristol Myers agrees with U.S. to make Eliquis available on Medicaid for free
18d ago
BMY
Trump announces pacts with nine pharma companies to lower drug prices
PremiumThe Fly
Trump announces pacts with nine pharma companies to lower drug prices
18d ago
BMY
GSK
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
PremiumThe Fly
Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
18d ago
AZN
BMY
Bristol Myers subsidiary gets orphan status for systemic sclerosis treatment
PremiumThe Fly
Bristol Myers subsidiary gets orphan status for systemic sclerosis treatment
18d ago
BMY
New Pumitamig Kidney Cancer Trial Adds Long-Term Optionality for Bristol-Myers Squibb and BioNTech
PremiumCompany Announcements
New Pumitamig Kidney Cancer Trial Adds Long-Term Optionality for Bristol-Myers Squibb and BioNTech
18d ago
BMY
BNTX
Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says
PremiumThe FlyTop drugmakers to enter agreements with U.S. to cut drug prices, Reuters says
18d ago
BMY
MRK
BMY and BNTX Advance New Immunotherapy Bet in First-Line Liver Cancer With ROSETTA HCC-206
Premium
Company Announcements
BMY and BNTX Advance New Immunotherapy Bet in First-Line Liver Cancer With ROSETTA HCC-206
19d ago
BMY
BNTX
Cytokinetics upgraded to Buy at Goldman on odds of ACACIA succeeding
Premium
The Fly
Cytokinetics upgraded to Buy at Goldman on odds of ACACIA succeeding
19d ago
BMY
CYTK
Bristol-Myers Squibb to Launch Phase 3 Trial for Schizophrenia Drug KarXT in Adolescents
PremiumCompany Announcements
Bristol-Myers Squibb to Launch Phase 3 Trial for Schizophrenia Drug KarXT in Adolescents
20d ago
BMY
Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology
PremiumCompany Announcements
Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology
20d ago
BMY
Analysts Warn That These 3 Stocks Could Sink Further – 12/16/2025
PremiumMarket News
Analysts Warn That These 3 Stocks Could Sink Further – 12/16/2025
21d ago
BMY
KMX
Bristol-Myers Squibb’s Study on Oral Anticoagulants in Elderly NVAF Patients: Market Insights
PremiumCompany Announcements
Bristol-Myers Squibb’s Study on Oral Anticoagulants in Elderly NVAF Patients: Market Insights
21d ago
BMY
Bristol Myers price target raised to $57 from $51 at Goldman Sachs
PremiumThe FlyBristol Myers price target raised to $57 from $51 at Goldman Sachs
22d ago
BMY
Bristol Myers upgraded to Buy at BofA on pipeline strength
Premium
The Fly
Bristol Myers upgraded to Buy at BofA on pipeline strength
22d ago
BMY
Bristol Myers upgraded to Buy from Neutral at BofA
Premium
The Fly
Bristol Myers upgraded to Buy from Neutral at BofA
22d ago
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >